MyAverix Finance
US · Healthcare
Alkermes Plc (ALKS)
Drug Manufacturers - Specialty & Generic
Alkermes Plc (ALKS) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ALKS
Alkermes Plc (ALKS) — FAQ
What is ALKS's P/E ratio?
The price-to-earnings (P/E) ratio for Alkermes Plc (ALKS) is 18.00 (data as of 2026-03-23).
Does Alkermes Plc pay a dividend?
Dividend yield is not available in the current snapshot for Alkermes Plc (ALKS). Check the MyAverix Finance app for the latest dividend data.
What sector is Alkermes Plc in?
Alkermes Plc (ALKS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is ALKS listed on?
ALKS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.